IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sanofi

Q2 2025 Holdings

Filed 2025-07-29 | 10 holdings | $175.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
MeiraGTx Holdings plc(MGTX)COMG59665102$79.5M12,197,73745.3%
Novavax(NVAX)COM NEW670002401$43.3M6,880,48124.7%
AnaptysBio(ANAB)COM032724106$18.2M821,91710.4%
Inhibrx Biosciences, Inc.(INBX)COM45720N103$16.5M1,157,9269.4%
Omada Health Inc.(OMDA)COM68170A108$9.6M524,9035.5%
Lava Therapeutics N.V.SHSN51517105$2.5M1,919,4551.4%
Eledon(ELDN)COM28617K101$2.2M814,9801.3%
Inozyme, IncCOM45790W108$1.8M443,2551.0%
IGM Biosciences(1K0)COM449585108$1.6M1,438,9750.9%
Q32 Bio Inc.(QTTB)COM746964105$363.7K244,0830.2%